News & Events
-
August 22, 2023
C-Path Welcomes ObvioHealth
C-Path is proud to welcome ObvioHealth, a virtual research organization (VRO), as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Comprised of 23 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, eCOA Consortium members collaborate in a pre-competitive... -
July 25, 2023
PRO Consortium and eCOA Consortium Announce Publication of an Open Access Article
C-Path’s PRO Consortium and eCOA Consortium are pleased to announce the publication of an open access article in the Value in Health, titled “Best Practice Recommendations for Electronic Patient-Reported Outcome (ePRO) Dataset Structure and Standardization to Support Drug Development.” This article provides best practice recommendations covering the application of CDISC standards to maintain the integrity of ePRO datasets, reduce stakeholder burden,... -
July 18, 2023
C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships
C-Path ts activity in Europe and broaden its global operations. C-Path operates in Europe as a nonprofit organisation that builds consensus among its stakeholders from around the world to improve public health. The organisation shares expertise, data, risks and costs to move regulatory science forward.
-
May 25, 2023
C-Path Welcomes Red Nucleus Clinical
C-Path is proud to welcome Red Nucleus Clinical as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Comprised of 22 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, eCOA Consortium members collaborate in a pre-competitive environment to support and conduct... -
March 29, 2023
C-Path Appoints Key Scientific Leaders to Executive Roles
TUCSON, Ariz., March 29, 2023 — Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the organization. Cheryl D. Coon, Ph.D., joins C-Path as the Vice President for the Clinical Outcome Assessment (COA) Program. Shu Chin Ma, Ph.D., M.Sc., M.Phil., EMBA, has been named Vice President of...